In addition, the ITPR1 of patients with triple-negative and basal breast cancer was significantly lower than that of patients with non-triple-negative and non-basal breast cancer (Fig. 3G, H, I, P < 0.0001). Here, ITPR1 is linked to breast carcinoma.